Literature DB >> 31207321

CCL18-induced HOTAIR upregulation promotes malignant progression in esophageal squamous cell carcinoma through the miR-130a-5p-ZEB1 axis.

Wenjian Wang1, Duoguang Wu1, Xiaotian He1, Xueting Hu1, Chuwen Hu2, Zhiwen Shen2, Jiatong Lin1, Zihao Pan1, Zhanghai He3, Huayue Lin4, Minghui Wang5.   

Abstract

Accumulating evidence indicates that CCL18 and the long non-coding RNA, HOTAIR, have critical roles in cancer progression and metastasis, but the correlation between CCL18 and HOTAIR in esophageal squamous cell carcinoma (ESCC) and their downstream molecular mechanisms remain unclear. Overexpression of CCL18 in ESCC tissues was associated with a worse survival in patients with ESCC. CCL18 enhanced the invasiveness of ESCC cells in a dose-dependent manner, whereas CCL18 knockdown inhibited their invasiveness. In particular, CCL18 expression was positively associated with HOTAIR expression in ESCC tissues. Furthermore, CCL18 upregulated the expression of HOTAIR, and knockdown of HOTAIR alleviated the CCL18-induced invasiveness of ESCC cells. HOTAIR may act as a competing endogenous RNA and could effectively becoming a sponge for miR-130a-5p, thereby modulating the derepression of ZEB1 and promoting epithelial-mesenchymal transition in ESCC. Our study suggests that CCL18 contributes to the malignant progression of esophageal cancer by upregulating HOTAIR expression. HOTAIR overexpression may promote tumor invasiveness and progression in ESCC, given that HOTAIR functions as a miR-130a-5p sponge, positively regulating ZEB1. This provides new therapeutic targets for early diagnosis and treatment of ESCC.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Long non-coding RNA; MicroRNA; ceRNA

Mesh:

Substances:

Year:  2019        PMID: 31207321     DOI: 10.1016/j.canlet.2019.06.009

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  27 in total

1.  CDK4/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism.

Authors:  Zhen Zhang; Jianjun Li; Yang Ou; Guang Yang; Kaiyuan Deng; Qiong Wang; Zhaoyang Wang; Wenhao Wang; Quansheng Zhang; Hang Wang; Wei Sun; Peiqing Sun; Shuang Yang
Journal:  Signal Transduct Target Ther       Date:  2020-03-11

Review 2.  The emerging role of long noncoding RNAs in esophageal carcinoma: from underlying mechanisms to clinical implications.

Authors:  Siyuan Luan; Yushang Yang; Yuxin Zhou; Xiaoxi Zeng; Xin Xiao; Bo Liu; Yong Yuan
Journal:  Cell Mol Life Sci       Date:  2021-01-19       Impact factor: 9.261

3.  Expression of CXCL12 in esophageal high grade dysplasia characterized pathologically by lymphocyte accumulation directly under the lesion.

Authors:  Kunio Mochizuki; Naoki Oishi; Toru Odate; Ippei Tahara; Tomohiro Inoue; Kazunari Kasai; Tetsuo Kondo
Journal:  Histol Histopathol       Date:  2021-12-17       Impact factor: 2.303

Review 4.  The Emerging Role of Long Non-Coding RNAs in Esophageal Cancer: Functions in Tumorigenesis and Clinical Implications.

Authors:  Yali Han; Guo Zhao; Xinhang Shi; Yushan Wang; Xin Wen; Lu Zhang; Xiangqian Guo
Journal:  Front Pharmacol       Date:  2022-05-13       Impact factor: 5.988

5.  The microRNA-130a-5p/RUNX2/STK32A network modulates tumor invasive and metastatic potential in non-small cell lung cancer.

Authors:  Fang Ma; Yangchun Xie; Yiyu Lei; Zengshuyu Kuang; Xianling Liu
Journal:  BMC Cancer       Date:  2020-06-22       Impact factor: 4.430

6.  LINC00473 contributes to the radioresistance of esophageal squamous cell carcinoma by regulating microRNA‑497‑5p and cell division cycle 25A.

Authors:  Wei-Hua Liu; Han-Yong Qiao; Jian Xu; Wei-Qing Wang; Yi-Lei Wu; Xia Wu
Journal:  Int J Mol Med       Date:  2020-05-25       Impact factor: 4.101

7.  LncRNA HOTAIR Contributes to Sorafenib Resistance through Suppressing miR-217 in Hepatic Carcinoma.

Authors:  Xiaofeng Tang; Weichen Zhang; Yufu Ye; Hong Li; Longyu Cheng; Min Zhang; Shusen Zheng; Jun Yu
Journal:  Biomed Res Int       Date:  2020-05-09       Impact factor: 3.411

8.  Targeted Inhibition of CCL22 by miR-130a-5p Can Enhance the Sensitivity of Cisplatin-Resistant Gastric Cancer Cells to Chemotherapy.

Authors:  Qing-Liang Fang; Kai-Chun Li; Lei Wang; Xiang-Lian Gu; Ren-Jie Song; Song Lu
Journal:  Cancer Manag Res       Date:  2020-05-26       Impact factor: 3.989

9.  CDK4/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism.

Authors:  Zhen Zhang; Jianjun Li; Yang Ou; Guang Yang; Kaiyuan Deng; Qiong Wang; Zhaoyang Wang; Wenhao Wang; Quansheng Zhang; Hang Wang; Wei Sun; Peiqing Sun; Shuang Yang
Journal:  Signal Transduct Target Ther       Date:  2020-03-11

Review 10.  CCL18 in the Progression of Cancer.

Authors:  Jan Korbecki; Mateusz Olbromski; Piotr Dzięgiel
Journal:  Int J Mol Sci       Date:  2020-10-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.